Regis appoints Matthew Doctor as permanent President and CEO, effective May 5, 2022

REGIS CORP

Matthew Doctor, 35, appointed President & CEO and director; had been interim CEO since Dec 2021.
Base salary $600K/yr, target bonus 125% of base, max payout 225%; granted options for 875,000 shares.
Options vest 20% on 1st anniversary, 20% on 2nd, 60% on 3rd; exercise price = closing price on grant date.
Doctor previously EVP & Chief Strategy Officer at Regis, earlier at Restaurant Brands International and J.P. Morgan.
Board chair David Grissen: 'Matt has stabilized the team, built trust with franchisees, laid groundwork for future.'

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Matthew Doctor

Director

RGS · REGIS CORP

Effective: 2022-05-05
Filed: May 5, 2022, 7:59 PM ET

On May 5, 2022, Regis Corporation (the "Company") announced Matthew Doctor as the Company's President and Chief Executive Officer (CEO) and will be appointed as a director on the Company's Board of Directors (the "Board") effective May 5, 2022 ("Start Date").

Appointed

Matthew Doctor

President and Chief Executive Officer

RGS · REGIS CORP

Effective: 2022-05-05
Filed: May 5, 2022, 7:59 PM ET

On May 5, 2022, Regis Corporation (the "Company") announced Matthew Doctor as the Company's President and Chief Executive Officer (CEO) and will be appointed as a director on the Company's Board of Directors (the "Board") effective May 5, 2022 ("Start Date").

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Matthew Doctor was appointed as Director at REGIS CORP.

Action: appointed
Role: Director

Exact text from the filing

On May 5, 2022, Regis Corporation (the "Company") announced Matthew Doctor as the Company's President and Chief Executive Officer (CEO) and will be appointed as a director on the Company's Board of Directors (the "Board") effective May 5, 2022 ("Start Date").

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Matthew Doctor was appointed as President and Chief Executive Officer at REGIS CORP.

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

On May 5, 2022, Regis Corporation (the "Company") announced Matthew Doctor as the Company's President and Chief Executive Officer (CEO) and will be appointed as a director on the Company's Board of Directors (the "Board") effective May 5, 2022 ("Start Date").

View on SEC.gov

REGIS CORP filing history →

Source: SEC EDGAR

accession 0000716643-22-000023

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.